Tumor Suppressor microRNAs Contribute to the Regulation of PD-L1 Expression in Malignant Pleural Mesothelioma

Steven Kao, Yuen Yee Cheng, Marissa Williams, +12

Journal of Thoracic Oncology

Tumor BiologyMalignant Pleural MesotheliomaPd-l1 ExpressionMedicinePathology +7

Dynamics of Chemokine, Cytokine, and Growth Factor Serum Levels in BRAF-Mutant Melanoma Patients during BRAF Inhibitor Treatment

James S. Wilmott, Lauren E. Haydu, Alexander M. Menzies, +7

The Journal of Immunology

Intrapatient Homogeneity of BRAFV600E Expression in Melanoma

Alexander M. Menzies, Trina Lum, James S. Wilmott, +6

The American Journal of Surgical Pathology

Intratumoral HeterogeneitySkin CancerTumor HeterogeneityMedicineBraf Status +13

Programmed cell death-ligand 1 expression in oral squamous cell carcinoma is associated with an inflammatory phenotype

Laveniya Satgunaseelan, Ruta Gupta, Jason Madore, +6

Pathology

Tumor BiologyMedicineApoptosisImmunologyPathology +9

Salivary duct carcinoma: clinicopathologic features, morphologic spectrum and somatic mutations

Peter P. Luk, Jared Weston, Bing Yu, +9

Breast OncologyPathologySalivary Duct CarcinomaFacial Nerve PalsySalivary Gland +15

Diagnostic and prognostic utility of Mastermind-like 2 (MAML2) gene rearrangement detection by fluorescent in situ hybridization (FISH) in mucoepidermoid carcinoma of the salivary glands

Peter P. Luk, James Wykes, Christina Selinger, +8

Oral Surgery Oral Medicine Oral Pathology and Oral Radiology

Tumor HeterogeneityMedicineGeneticsPathologySalivary Glands +7

Screening for <i><scp>ROS</scp>1</i> gene rearrangements in non‐small‐cell lung cancers using immunohistochemistry with <scp>FISH</scp> confirmation is an effective method to identify this rare target

Christina Selinger, Bob T. Li, Nick Pavlakis, +12

Histopathology

PD-L1 expression predicts longer disease free survival in high risk head and neck cutaneous squamous cell carcinoma

Edward Roper, Trina Lum, Carsten E. Palme, +6

Pathology

Pd-l1 ExpressionMedicinePathologyHigh Risk HeadImmune Checkpoint Inhibitor +7

Primary and Metastatic Cutaneous Melanomas Express ALK Through Alternative Transcriptional Initiation

Klaus J. Busam, Ricardo E. Vilain, Trina Lum, +6

The American Journal of Surgical Pathology

BRAF mutations in non-small cell lung cancer.

Peter P. Luk, Bing Yu, Chiu Chin Ng, +6

PubMed